Quarterly report pursuant to Section 13 or 15(d)

Non-Controlling Interests - Summary Of Components of Non-Controlling Interests in Loss of Consolidated Entities (Detail)

v3.3.0.814
Non-Controlling Interests - Summary Of Components of Non-Controlling Interests in Loss of Consolidated Entities (Detail) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Noncontrolling Interest [Line Items]        
Non-controlling interests in loss of consolidated entities $ (1,694) $ 0 $ (2,416) $ 0
Avenue [Member]        
Noncontrolling Interest [Line Items]        
Non-controlling interests in loss of consolidated entities $ (367)   $ (401)  
Non-controlling ownership (See Note 4) 11.50%   11.50%  
Coronado SO Co, Inc [Member]        
Noncontrolling Interest [Line Items]        
Non-controlling interests in loss of consolidated entities $ (7)   $ (237)  
Non-controlling ownership (See Note 4) 13.00%   13.00%  
Mustang Therapeutics, Inc [Member]        
Noncontrolling Interest [Line Items]        
Non-controlling interests in loss of consolidated entities $ (54)   $ (321)  
Non-controlling ownership (See Note 4) 10.00%   10.00%  
Checkpoint Therapeutics, Inc [Member]        
Noncontrolling Interest [Line Items]        
Non-controlling interests in loss of consolidated entities $ (977)   $ (1,168)  
Non-controlling ownership (See Note 4) 20.00%   20.00%  
JMC [Member]        
Noncontrolling Interest [Line Items]        
Non-controlling interests in loss of consolidated entities $ (289)   $ (289)  
Non-controlling ownership (See Note 4) 25.00%   25.00%